Health
CoVIg-19 Plasma Alliance announces outcomes of NIH-funded Phase 3 ITAC clinical trial – News-Medical.Net
The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded…

The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), did not meet its endpoints. No serious safety signals were raised in the trial.
The study aimed to determine whether an investigational anti-coronavirus hyperimmune intravenous immunoglobulin (H-Ig) medicine (referred to…
-
Noosa News18 hours ago
Queensland weather forecast sees sunny weather for last week of winter
-
Noosa News19 hours ago
Forum responds to urgent homelessness issues in Nambour
-
Business16 hours ago
Why the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General18 hours ago
Energy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers